Results 31 to 40 of about 1,948,743 (254)

Incidence of PONV grouped by concomitant anti-emetics.

open access: yes, 2014
Eleven studies described the incidence of PONV in thyroidectomy patients treated with dexamethasone versus placebo with or without concomitant anti-emetics (RR 0.52, 95% CI 0.43 to 0.63 ...
Zhenhong Zou (645858)   +3 more
core   +1 more source

Need for rescue analgesics grouped by concomitant anti-emetics.

open access: yes, 2014
Six studies described the need for rescue analgesics in thyroidectomy patients treated with dexamethasone versus placebo with or without concomitant anti-emetics (RR 0.65, 95% CI 0.50–0.83, P = 0.0008).
Zhenhong Zou (645858)   +3 more
core   +1 more source

Details of anesthetic technique, and rescue analgesics and anti-emetics in the included trials.

open access: yes, 2014
IV, intravenous; IM, intramuscular; ano difference.Details of anesthetic technique, and rescue analgesics and anti-emetics in the included trials.
Zhenhong Zou (645858)   +3 more
core   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Intravenous palonosetron compared with a combination of ramosetron and dexamethasone in preventing post operative nausea and vomiting in patients undergoing gynaecological surgeries under spinal anaesthesia, a randomised study

open access: yesIndian Journal of Anaesthesia, 2017
Background and Aims: Post-operative nausea and vomiting (PONV) is one of the most common complications in patients undergoing gynaecological surgeries under spinal anaesthesia (SA).
Archana B Narayanappa   +5 more
doaj   +1 more source

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

open access: yesPharmaceutics, 2020
Potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are based on their activity as analgesics, anti-emetics, anti-inflammatory agents, anti-seizure compounds.
Fabrizio Calapai   +6 more
doaj   +1 more source

Re‐Purposing Sapropterin (Kuvan) for ACTA2‐Related Multisystemic Smooth Muscle Dysfunction Syndrome: A Translational Mechanistic and First‐In‐Human Therapeutic Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Multisystemic smooth muscle dysfunction syndrome (MSMDS) is an ultra‐rare, ACTA2‐related disorder characterized by severe cerebrovascular disease, aortic aneurysms, and smooth muscle dysfunction. Using molecular dynamics simulations and in silico drug screening, we identified that sapropterin dihydrochloride (Kuvan) is a candidate capable of ...
Moran Hausman‐Kedem   +9 more
wiley   +1 more source

Comparative study on effects of dexmedetomidine and dexamethasone on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic surgery

open access: yesJournal of Acute Disease, 2022
Objective: To compare the safety and efficacy of dexmedetomidine and dexamethasone for the prevention of postoperative nausea and vomiting (PONV) in patients scheduled for laparoscopic surgery.
Manpreet Singh   +6 more
doaj   +1 more source

Update on anti-emetics for chemotherapy-induced emesis

open access: yes, 2005
The need to control chemotherapy-induced emesis has stimulated research into anti-emetics. Emesis is not only unpleasant, but negatively impacts on global quality of life.
Olver, I.
core   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Home - About - Disclaimer - Privacy